Hemophilia A; Hema
Description
Hemophilia A is an X-linked recessive bleeding disorder caused by a deficiency in the activity of coagulation factor VIII. The disorder is clinically heterogeneous with variable severity, depending on the plasma levels of coagulation factor VIII: mild, with levels 6 to 30% of normal; moderate, with levels 2 to 5% of normal; and severe, with levels less than 1% of normal. Patients with mild hemophilia usually bleed excessively only after trauma or surgery, whereas those with severe hemophilia have an annual average of 20 to 30 episodes of spontaneous or excessive bleeding after minor trauma, particularly into joints and muscles. These symptoms differ substantially from those of bleeding disorders due to platelet defects or von Willebrand disease (OMIM ), in which mucosal bleeding predominates (review by Mannucci and Tuddenham, 2001).
Clinical Features
Top most frequent phenotypes and symptoms related to Hemophilia A; Hema
- Pain
- Anemia
- Flexion contracture
- Peripheral neuropathy
- Blindness
- Arthralgia
- Arthritis
- Stroke
- Muscular dystrophy
- Bruising susceptibility
And another 20 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available HEMOPHILIA A; HEMA have a estimated birth prevalence of 11.25 per 100k in Europe.— No data available about the known clinical features onset.
Alternative names
Hemophilia A; Hema Is also known as hemophilia, classic.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Hemophilia A; Hema Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center (United States).
F8
Specificity
100 %
Genes
100 % |
![]() By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center (United States).
F8
Specificity
100 %
Genes
100 % |
![]() By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center (United States).
F8
Specificity
100 %
Genes
100 % |
![]() By Genomics - Bleeding Disorders BloodworksNW (United States).
F8
Specificity
100 %
Genes
100 % |
![]() By Genomics - Bleeding Disorders BloodworksNW (United States).
F8
Specificity
100 %
Genes
100 % |
![]() By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
RUNX1, STIM1, TBXA2R, TBXAS1, USF1, VPS33B, VWF, WAS, GP6, HPS3, HPS4, CD36, HPS5, DTNBP1, P2RY12, HPS6, MASTL, LYST, VIPAS39, FERMT3 , (...)
View the complete list with 34 more genes
Specificity
2 %
Genes
100 % |
![]() By Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine (United States).
F8
Specificity
100 %
Genes
100 % |
![]() By Genetic Diagnostic Laboratory University of Pennsylvania School of Medicine (United States).
F8
Specificity
100 %
Genes
100 % |
You can get up to 57 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MECKEL SYNDROME, TYPE 2; MKS2 ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13 AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 2; EBSB2 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5 FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4 CATARACT 2, MULTIPLE TYPES; CTRCT2